Fully Human Antibodies for Malignant Pleural Mesothelioma Targeting

Immunotherapy is the most promising therapeutic approach against malignant pleural mesothelioma (MPM). Despite technological progress, the number of targetable antigens or specific antibodies is limited, thus hindering the full potential of recent therapeutic interventions. All possibilities of find...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolini, Fabio, Bocchini, Martine, Angeli, Davide, Bronte, Giuseppe, Delmonte, Angelo, Crinò, Lucio, Mazza, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226231/
https://www.ncbi.nlm.nih.gov/pubmed/32276524
http://dx.doi.org/10.3390/cancers12040915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226231/
https://www.ncbi.nlm.nih.gov/pubmed/32276524
http://dx.doi.org/10.3390/cancers12040915

Ejemplares similares